ea0090p335 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023
Jeong In-Kyung
, Mook Choi Kyung
, Ah Han Kyung
, Kim Kyoung-Ah
, kim injoo
, jin Han Seung
, Wan Lee Byung
, Lee Won-Young
, Jib Yoo Soon
Background and aims: The efficacy and safety of dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus (T2DM) and inadequate glycemic control with evogliptin and metformin combinations was investigated.Materials and methods: Patients with HbA1c of 7.0% to 10.5% receiving evogliptin 5mg and metformin ≥1000 mg were randomized to receive dapagliflozin 10 mg/day (n=99) or placebo (n=99) for 24 weeks. The primary end...